A simple and rapid method for preliminary evaluation of in vivo efficacy of anti-HIV compounds in mice
- 1 May 1995
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 27 (1-2) , 151-163
- https://doi.org/10.1016/0166-3542(95)00004-6
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Kynostatin (KNI-227 and -272, highly potent anti-HIV agents: conformationally constrained tripeptide inhibitors of HIV protease containing allophenylnorstatine.CHEMICAL & PHARMACEUTICAL BULLETIN, 1992
- hu‐PBL‐SCID Mice: A Model for Human Immune Function, AIDS, and LymphomagenesisImmunological Reviews, 1991
- Rational Design of Peptide-Based HIV Proteinase InhibitorsScience, 1990
- Suppression of HIV Infection in AZT-Treated SCID-hu MiceScience, 1990
- Preformulation solubility and kinetic studies of 2',3'-dideoxypurine nucleosides: potential anti-AIDS agentsInternational Journal of Pharmaceutics, 1988
- Long-term Persistent Infection of Macaque Monkeys with the Simian Immunodeficiency VirusJournal of General Virology, 1987
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- Isolation of a T-Lymphotropic Virus from Domestic Cats with an Immunodeficiency-Like SyndromeScience, 1987
- Suppression of mouse viraemia and retroviral disease by 3′-azido-3′-deoxythymidineNature, 1986
- Infection of HTLV-III/LAV in HTLV-I-Carrying Cells MT-2 and MT-4 and Application in a Plaque AssayScience, 1985